| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2972627 | The Journal of Heart and Lung Transplantation | 2007 | 7 Pages |
Abstract
These results suggest that basiliximab offers improved tolerability with similar efficacy compared with current polyclonal antibody induction therapy in de novo heart transplant patients.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Marie Françoise MD, Michel MD, Iradj MD, Annick Mouly MD, Allain MD, Eric MD, Romain MD, Bernard MD, Annie MD, Michelle MD, Emmanuelle MD, Richard MD, Djamila MD, Anne Sandrine MD, Pascale MD,